Photo shows several empty pill blisters on a surface.Share on Pinterest
Scientists have discovered that a form of vitamin D could help reduce lung inflammation in COVID-19. Zoonar RF/Getty Images
  • A special form of Vitamin D — not found over the counter (OTC) — may be able to combat lung inflammation caused by immune cells, a new study suggests.
  • The research shows vitamin D has a “switch-off” mechanism for inflammation, which could work in severe COVID-19.
  • However, clinical trials are needed before vitamin D is adopted to treat COVID-19 or other respiratory diseases.
  • The researchers warn against people taking more than the recommended amount of vitamin D in hopes of staving off COVID-19 infection.

Scientists are sharing insight into how vitamin D could help in severe COVID-19 cases by revealing how the vitamin functions to reduce hyper-inflammation caused by immune cells.

A new joint study by Purdue University and the National Institutes of Health (NIH) demonstrates how an active metabolite of vitamin D — not a form sold OTC — is involved in “switching off” inflammation in the body during infections such as COVID-19.

“Since inflammation in severe cases of COVID-19 is a key reason for morbidity and mortality, we decided to take a closer look at lung cells from COVID-19 patients,” said lead authors Dr. Behdad (Ben) Afzali, chief of the Immunoregulation Section of the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases, and Dr. Majid Kazemian, assistant professor of biochemistry and computer science at Purdue University.

The study appears in the journal Nature ImmunologyTrusted Source.

https://www.medicalnewstoday.com/articles/study-shows-how-vitamin-d-could-halt-lung-inflammation-in-covid-19